Enviar pesquisa
Carregar
Rb ll etal cessation assistance in 15 countries
•
0 gostou
•
324 visualizações
A
Alexander Li
Seguir
Saúde e medicina
Denunciar
Compartilhar
Denunciar
Compartilhar
1 de 9
Baixar agora
Baixar para ler offline
Recomendados
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
Δρ. Γιώργος K. Κασάπης
Trends_in_Primary_Methamphetamine-Relate
Trends_in_Primary_Methamphetamine-Relate
Marina Neurochevski
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
University of Michigan Injury Center
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
University of Michigan Injury Center
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
University of Michigan Injury Center
Access to subsidised nicotine replacement therapy in South Auckland
Access to subsidised nicotine replacement therapy in South Auckland
Simon Thornley
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
OPUNITE
David Borsook, "Opioids for Chronic Pain: Where is the Science for the Clinic...
David Borsook, "Opioids for Chronic Pain: Where is the Science for the Clinic...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
Recomendados
New study supports notion of skewed opioid prescribing
New study supports notion of skewed opioid prescribing
Δρ. Γιώργος K. Κασάπης
Trends_in_Primary_Methamphetamine-Relate
Trends_in_Primary_Methamphetamine-Relate
Marina Neurochevski
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
University of Michigan Injury Center
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
Opioid Surveillance and Policy: A Canadian Perspective by Tara Gomes, MHSc
University of Michigan Injury Center
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
University of Michigan Injury Center
Access to subsidised nicotine replacement therapy in South Auckland
Access to subsidised nicotine replacement therapy in South Auckland
Simon Thornley
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
OPUNITE
David Borsook, "Opioids for Chronic Pain: Where is the Science for the Clinic...
David Borsook, "Opioids for Chronic Pain: Where is the Science for the Clinic...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
Twillman preventing rx abuse
Twillman preventing rx abuse
American Academy of Family Physicians
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
PIIS0140673611607010
PIIS0140673611607010
Mario Christodoulou
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
University of Michigan Injury Center
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
University of Michigan Injury Center
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Virginia Mason Internal Medicine Residency
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
1471 2458-11-75
1471 2458-11-75
Julia Purpera
The use of cessation assistance among smokers from china findings from the ...
The use of cessation assistance among smokers from china findings from the ...
Julia Purpera
PROs and Patient Preference Studies
PROs and Patient Preference Studies
Sheily Kamra
Installment 5
Installment 5
Kevin Tebrugge
Progress and Challenges in Expanding the Role of Health Care Providers and De...
Progress and Challenges in Expanding the Role of Health Care Providers and De...
Global Bridges
Utah Drug Overdose Mortality
Utah Drug Overdose Mortality
State of Utah, Salt Lake City
The australian quit coach published version
The australian quit coach published version
Alexander Li
NSR2014
NSR2014
Georgi Daskalov
Tx 3 hill shuman_oliver
Tx 3 hill shuman_oliver
OPUNITE
Opioids & Oregon Medicaid
Opioids & Oregon Medicaid
Paul Coelho, MD
Survey Report on Current Hard Drug Users in Nepal -2069
Survey Report on Current Hard Drug Users in Nepal -2069
Niraj Bartaula
Is drug checking effective at reducing harm? A systematic review
Is drug checking effective at reducing harm? A systematic review
UNSW
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
University of Michigan Injury Center
Li et-al -impact-of-point-of-sale-anti-smoking-warnings1
Li et-al -impact-of-point-of-sale-anti-smoking-warnings1
Alexander Li
Tobacco advertising in china compared to thailand australia usa
Tobacco advertising in china compared to thailand australia usa
Alexander Li
Mais conteúdo relacionado
Mais procurados
Twillman preventing rx abuse
Twillman preventing rx abuse
American Academy of Family Physicians
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
PIIS0140673611607010
PIIS0140673611607010
Mario Christodoulou
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
University of Michigan Injury Center
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
University of Michigan Injury Center
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Virginia Mason Internal Medicine Residency
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics
1471 2458-11-75
1471 2458-11-75
Julia Purpera
The use of cessation assistance among smokers from china findings from the ...
The use of cessation assistance among smokers from china findings from the ...
Julia Purpera
PROs and Patient Preference Studies
PROs and Patient Preference Studies
Sheily Kamra
Installment 5
Installment 5
Kevin Tebrugge
Progress and Challenges in Expanding the Role of Health Care Providers and De...
Progress and Challenges in Expanding the Role of Health Care Providers and De...
Global Bridges
Utah Drug Overdose Mortality
Utah Drug Overdose Mortality
State of Utah, Salt Lake City
The australian quit coach published version
The australian quit coach published version
Alexander Li
NSR2014
NSR2014
Georgi Daskalov
Tx 3 hill shuman_oliver
Tx 3 hill shuman_oliver
OPUNITE
Opioids & Oregon Medicaid
Opioids & Oregon Medicaid
Paul Coelho, MD
Survey Report on Current Hard Drug Users in Nepal -2069
Survey Report on Current Hard Drug Users in Nepal -2069
Niraj Bartaula
Is drug checking effective at reducing harm? A systematic review
Is drug checking effective at reducing harm? A systematic review
UNSW
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
University of Michigan Injury Center
Mais procurados
(20)
Twillman preventing rx abuse
Twillman preventing rx abuse
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
Monica Bharel, "Addressing the Opioid Epidemic through a Public Health Lens"
PIIS0140673611607010
PIIS0140673611607010
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
Naloxone for Opioid Safety by Phillip Coffin, MD, MIA
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Changes in Provider Prescribing Patterns After Implementation of an Emergency...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
Rita Nieves, "Boston Public Health Commission: A City's Health Department Per...
1471 2458-11-75
1471 2458-11-75
The use of cessation assistance among smokers from china findings from the ...
The use of cessation assistance among smokers from china findings from the ...
PROs and Patient Preference Studies
PROs and Patient Preference Studies
Installment 5
Installment 5
Progress and Challenges in Expanding the Role of Health Care Providers and De...
Progress and Challenges in Expanding the Role of Health Care Providers and De...
Utah Drug Overdose Mortality
Utah Drug Overdose Mortality
The australian quit coach published version
The australian quit coach published version
NSR2014
NSR2014
Tx 3 hill shuman_oliver
Tx 3 hill shuman_oliver
Opioids & Oregon Medicaid
Opioids & Oregon Medicaid
Survey Report on Current Hard Drug Users in Nepal -2069
Survey Report on Current Hard Drug Users in Nepal -2069
Is drug checking effective at reducing harm? A systematic review
Is drug checking effective at reducing harm? A systematic review
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Group Health Risk Reduction Initiatives: Can Opioid Dose Reduction Reduce Har...
Destaque
Li et-al -impact-of-point-of-sale-anti-smoking-warnings1
Li et-al -impact-of-point-of-sale-anti-smoking-warnings1
Alexander Li
Tobacco advertising in china compared to thailand australia usa
Tobacco advertising in china compared to thailand australia usa
Alexander Li
L2 all au plain packaging
L2 all au plain packaging
Alexander Li
S25 2 how do we measure secondhand smoke- erika avila-tang
S25 2 how do we measure secondhand smoke- erika avila-tang
Alexander Li
Careers outside Academia - USC Computer Science Masters and Ph.D. Students
Careers outside Academia - USC Computer Science Masters and Ph.D. Students
Ashwin Rao
S6 all
S6 all
Alexander Li
S32 6 movies are products - stanton glantz
S32 6 movies are products - stanton glantz
Alexander Li
Careers in Quant Finance talk at UCLA Financial Engineering
Careers in Quant Finance talk at UCLA Financial Engineering
Ashwin Rao
S22 1 hazards of smoking and the benefits of stopping- sir richard peto
S22 1 hazards of smoking and the benefits of stopping- sir richard peto
Alexander Li
Liu rl et al second hand smoke in restaurants and bars
Liu rl et al second hand smoke in restaurants and bars
Alexander Li
Web analytics
Web analytics
racerunner
Columbia CS - Roles in Quant Finance
Columbia CS - Roles in Quant Finance
Ashwin Rao
Pseudo and Quasi Random Number Generation
Pseudo and Quasi Random Number Generation
Ashwin Rao
Career Advice at University College of London, Mathematics Department.
Career Advice at University College of London, Mathematics Department.
Ashwin Rao
Stanford FinMath - Careers in Quant Finance
Stanford FinMath - Careers in Quant Finance
Ashwin Rao
Best Maldives Resort
Best Maldives Resort
Maldivesx2
Berkeley Financial Engineering - Guidance on Careers in Quantitative Finance
Berkeley Financial Engineering - Guidance on Careers in Quantitative Finance
Ashwin Rao
Destaque
(17)
Li et-al -impact-of-point-of-sale-anti-smoking-warnings1
Li et-al -impact-of-point-of-sale-anti-smoking-warnings1
Tobacco advertising in china compared to thailand australia usa
Tobacco advertising in china compared to thailand australia usa
L2 all au plain packaging
L2 all au plain packaging
S25 2 how do we measure secondhand smoke- erika avila-tang
S25 2 how do we measure secondhand smoke- erika avila-tang
Careers outside Academia - USC Computer Science Masters and Ph.D. Students
Careers outside Academia - USC Computer Science Masters and Ph.D. Students
S6 all
S6 all
S32 6 movies are products - stanton glantz
S32 6 movies are products - stanton glantz
Careers in Quant Finance talk at UCLA Financial Engineering
Careers in Quant Finance talk at UCLA Financial Engineering
S22 1 hazards of smoking and the benefits of stopping- sir richard peto
S22 1 hazards of smoking and the benefits of stopping- sir richard peto
Liu rl et al second hand smoke in restaurants and bars
Liu rl et al second hand smoke in restaurants and bars
Web analytics
Web analytics
Columbia CS - Roles in Quant Finance
Columbia CS - Roles in Quant Finance
Pseudo and Quasi Random Number Generation
Pseudo and Quasi Random Number Generation
Career Advice at University College of London, Mathematics Department.
Career Advice at University College of London, Mathematics Department.
Stanford FinMath - Careers in Quant Finance
Stanford FinMath - Careers in Quant Finance
Best Maldives Resort
Best Maldives Resort
Berkeley Financial Engineering - Guidance on Careers in Quantitative Finance
Berkeley Financial Engineering - Guidance on Careers in Quantitative Finance
Semelhante a Rb ll etal cessation assistance in 15 countries
Harm reduction atma jaya
Harm reduction atma jaya
Herrupribadi77
Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...
Georgi Daskalov
Global implementation of Harm Reduction
Global implementation of Harm Reduction
IDHDP
Unassisted cessation
Unassisted cessation
UCT ICO
Developing and Implementing a Smoking Cessation Intervention in Primary Care...
Developing and Implementing a Smoking Cessation Intervention in Primary Care...
COMDIS Health Service Delivery Research Consortium (Uni of Leeds)
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
Mubbashir hameed hospital pharmacist
Deloitte_ES_Sanidad-sanidad-en-europa.pdf
Deloitte_ES_Sanidad-sanidad-en-europa.pdf
janethlopez72
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenas
josepmariabadenas
Smoking cessation programme in luton
Smoking cessation programme in luton
Yemisi Oluwafemi
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
Office of Health Economics
Fix stop%20smoking%20medication%20use
Fix stop%20smoking%20medication%20use
Tobacco Commons
Fix stop smoking medication use
Fix stop smoking medication use
Tobacco Commons
Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?
Office of Health Economics
1471-2458-12-876
1471-2458-12-876
Maja Kiselinova
Effectiveness of a chat-bot for the adult population to quit smoking: protoco...
Effectiveness of a chat-bot for the adult population to quit smoking: protoco...
Jose Avila De Tomas
MPOWER Brochure
MPOWER Brochure
Smoke-Free Albay Network
Arpitkumar Patel Updated
Arpitkumar Patel Updated
Arpit Arunbhai Patel
First model of one stop service for drug users in drug dependent centers in s...
First model of one stop service for drug users in drug dependent centers in s...
Alexander Decker
Directed Project
Directed Project
Krishna Yanamandra
Clinical review supporting smoking cessationqqqqqqq11111
Clinical review supporting smoking cessationqqqqqqq11111
Georgi Daskalov
Semelhante a Rb ll etal cessation assistance in 15 countries
(20)
Harm reduction atma jaya
Harm reduction atma jaya
Health-care interventions to promote and assist tobacco cessation: a review o...
Health-care interventions to promote and assist tobacco cessation: a review o...
Global implementation of Harm Reduction
Global implementation of Harm Reduction
Unassisted cessation
Unassisted cessation
Developing and Implementing a Smoking Cessation Intervention in Primary Care...
Developing and Implementing a Smoking Cessation Intervention in Primary Care...
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
Deloitte_ES_Sanidad-sanidad-en-europa.pdf
Deloitte_ES_Sanidad-sanidad-en-europa.pdf
Globalization Of Clinical Trials 2010 Josep M. Badenas
Globalization Of Clinical Trials 2010 Josep M. Badenas
Smoking cessation programme in luton
Smoking cessation programme in luton
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
Fix stop%20smoking%20medication%20use
Fix stop%20smoking%20medication%20use
Fix stop smoking medication use
Fix stop smoking medication use
Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?
1471-2458-12-876
1471-2458-12-876
Effectiveness of a chat-bot for the adult population to quit smoking: protoco...
Effectiveness of a chat-bot for the adult population to quit smoking: protoco...
MPOWER Brochure
MPOWER Brochure
Arpitkumar Patel Updated
Arpitkumar Patel Updated
First model of one stop service for drug users in drug dependent centers in s...
First model of one stop service for drug users in drug dependent centers in s...
Directed Project
Directed Project
Clinical review supporting smoking cessationqqqqqqq11111
Clinical review supporting smoking cessationqqqqqqq11111
Mais de Alexander Li
Borland li etal effects of a fact sheet harm reduction journal2012
Borland li etal effects of a fact sheet harm reduction journal2012
Alexander Li
Ll etal itc 4 pos warnings and quitting-addiction_published
Ll etal itc 4 pos warnings and quitting-addiction_published
Alexander Li
Kasza li etal the effectiveness of tobacco marketing regulations int j enviro...
Kasza li etal the effectiveness of tobacco marketing regulations int j enviro...
Alexander Li
The acceptibility of nicotine products two pilot studies
The acceptibility of nicotine products two pilot studies
Alexander Li
Li et al china predictors of quitting paper published version
Li et al china predictors of quitting paper published version
Alexander Li
Beliefs about the relative harm of light and low tar cigs itc china
Beliefs about the relative harm of light and low tar cigs itc china
Alexander Li
Factors associated with intentions to quit itc china
Factors associated with intentions to quit itc china
Alexander Li
Predictors of smoking cessation in malaysia and thailand
Predictors of smoking cessation in malaysia and thailand
Alexander Li
S31 1 integrating tobacco control and maternal and child health to achieve th...
S31 1 integrating tobacco control and maternal and child health to achieve th...
Alexander Li
S31 1 integrating tobacco control and maternal and child health to achieve th...
S31 1 integrating tobacco control and maternal and child health to achieve th...
Alexander Li
S26 5 smoking, standard of living, and poverty in china- hu teh-wei
S26 5 smoking, standard of living, and poverty in china- hu teh-wei
Alexander Li
Hp1 1 the tobacco altas 10th anniversay
Hp1 1 the tobacco altas 10th anniversay
Alexander Li
S21 all
S21 all
Alexander Li
S15 all
S15 all
Alexander Li
S3 all
S3 all
Alexander Li
杀鸡取蛋
杀鸡取蛋
Alexander Li
社区空间使用指南.Pdf
社区空间使用指南.Pdf
Alexander Li
Mais de Alexander Li
(17)
Borland li etal effects of a fact sheet harm reduction journal2012
Borland li etal effects of a fact sheet harm reduction journal2012
Ll etal itc 4 pos warnings and quitting-addiction_published
Ll etal itc 4 pos warnings and quitting-addiction_published
Kasza li etal the effectiveness of tobacco marketing regulations int j enviro...
Kasza li etal the effectiveness of tobacco marketing regulations int j enviro...
The acceptibility of nicotine products two pilot studies
The acceptibility of nicotine products two pilot studies
Li et al china predictors of quitting paper published version
Li et al china predictors of quitting paper published version
Beliefs about the relative harm of light and low tar cigs itc china
Beliefs about the relative harm of light and low tar cigs itc china
Factors associated with intentions to quit itc china
Factors associated with intentions to quit itc china
Predictors of smoking cessation in malaysia and thailand
Predictors of smoking cessation in malaysia and thailand
S31 1 integrating tobacco control and maternal and child health to achieve th...
S31 1 integrating tobacco control and maternal and child health to achieve th...
S31 1 integrating tobacco control and maternal and child health to achieve th...
S31 1 integrating tobacco control and maternal and child health to achieve th...
S26 5 smoking, standard of living, and poverty in china- hu teh-wei
S26 5 smoking, standard of living, and poverty in china- hu teh-wei
Hp1 1 the tobacco altas 10th anniversay
Hp1 1 the tobacco altas 10th anniversay
S21 all
S21 all
S15 all
S15 all
S3 all
S3 all
杀鸡取蛋
杀鸡取蛋
社区空间使用指南.Pdf
社区空间使用指南.Pdf
Último
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
saminamagar
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
Dolisha Warbi
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
saminamagar
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
saminamagar
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
SasikiranMarri
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
Dolisha Warbi
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
ibtesaam huma
Epilepsy
Epilepsy
Arunagiri17
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
Dr.Nusrat Tariq
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
saminamagar
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
jennyeacort
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Sreeja Cherukuru
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
drashraf369
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
Mohamed Rizk Khodair
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
Prerana Jadhav
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
Arunagarwal328757
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
SasikiranMarri
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
Mohamed Rizk Khodair
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
kedirjemalharun
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
Dr. Dheeraj Kumar
Último
(20)
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Epilepsy
Epilepsy
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
Rb ll etal cessation assistance in 15 countries
1.
RESEARCH REPORT
doi:10.1111/j.1360-0443.2011.03636.x Cessation assistance reported by smokers in 15 countries participating in the International Tobacco Control (ITC) policy evaluation surveys add_3636 197..205 Ron Borland1, Lin Li1, Pete Driezen2, Nick Wilson3, David Hammond2, Mary E. Thompson2, Geoffrey T. Fong2, Ute Mons4, Marc C. Willemsen5, Ann McNeill6, James F. Thrasher7 & K. Michael Cummings8 The Cancer Council Victoria, Carlton, Victoria, Australia,1 The University of Waterloo, Waterloo, ON, Canada,2 University of Otago, Dunedin, New Zealand,3 German Cancer Research Center, Heidelberg, Germany,4 CAPHRI, Maastricht University, Maastricht, the Netherlands,5 University of Nottingham, Nottingham, UK,6 University of South Carolina, Columbia, SC, USA and National Institute of Public Health, Mexico City, Mexico7 and Roswell Park Cancer Institute, Buffalo, New York, USA8 ABSTRACT Aims To describe some of the variability across the world in levels of quit smoking attempts and use of various forms of cessation support. Design Use of the International Tobacco Control Policy Evaluation Project surveys of smokers, using the 2007 survey wave (or later, where necessary). Settings Australia, Canada, China, France, Germany, Ireland, Malaysia, Mexico, the Netherlands, New Zealand, South Korea, Thailand, United Kingdom, Uruguay and United States. Participants Samples of smokers from 15 countries. Measurements Self-report on use of cessation aids and on visits to health professionals and provision of cessation advice during the visits. Findings Prevalence of quit attempts in the last year varied from less than 20% to more than 50% across countries. Similarly, smokers varied greatly in reporting visiting health professionals in the last year (<20% to over 70%), and among those who did, provision of advice to quit also varied greatly. There was also marked variability in the levels and types of help reported. Use of medication was generally more common than use of behavioural support, except where medications are not readily available. Conclusions There is wide variation across countries in rates of attempts to stop smoking and use of assistance with higher overall use of medication than behavioural support. There is also wide variation in the provision of brief advice to stop by health professionals. Keywords Country differences, quitting activity, quitting aids, quitting medications, smoking cessation, survey. Correspondence to: Ron Borland, The Cancer Council Victoria, 1 Rathdowne Street, Carlton, Vic. 3053, Australia. E-mail: ron.borland@cancervic.org.au Submitted 20 March 2011; initial review completed 18 May 2011; final version accepted 21 August 2011 INTRODUCTION of treatment systems indicate a variety of models in place, with the greatest challenges being faced by large, The global community, through the World Health Orga- lower-income countries [3]. However, very little is known nization’s Framework Convention on Tobacco Control about quitting activity within countries, how this varies (FCTC), has agreed Guidelines for the implementation of as a result of the availability of different treatment Article 14 of the Convention, which deals with support systems and how this might inform the development of for smoking cessation. Recent studies have shown that treatment systems across different countries. few countries have developed comprehensive support Before smokers consider using cessation aids, they systems to help people to stop smoking [1,2]. Case studies need to be interested in quitting smoking. Health-care Additional contributions: Other leaders of ITC projects who checked the paper for appropriateness of any claims made about their countries were: Romain Guignard (French Institute for Health Promotion and Health Education, INPES, France), Martina Poetschke-Langer (German Cancer Research Center, Germany), Yuan Jiang (Chinese Center for Disease Control and Prevention, China), Hong-Gwan Seo (National Cancer Institute, South Korea), Edna Arillo-Santillán (Mexico), Marcelo Boado (Uruguay), Buppha Sirirassamee (Mahidol University, Thailand), Maizurah Omar (Universiti Sains Malaysia, Malaysia) and Gerard Hastings (Stirling and Open Universities, UK). © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
2.
198
Ron Borland et al. services can only contribute directly to this interest when tudinal studies (usually with replenishment), and in smokers use them, e.g. in consultations with health pro- those countries a majority of those surveyed were exist- fessionals. Advice from health-care professionals can ing members of the cohorts. We have chosen the survey increase successful quitting [4], medications such as wave closest to 2007 in each country that has the bulk of nicotine replacement therapy (NRT) and varenicline are the relevant measures. Details of the individual studies effective [5,6] and a range of support, ranging from auto- can be found at http://www.itcproject.org mated personalized advice, through quitlines to face-to- Sample size by country and other details are in face programmes, have also been shown to be effective Table 1. The survey data are weighted to the age and sex [7,8]. distribution of smokers in the relevant populations. As This paper reports comparative data on the prevalence can be seen from Table 1, survey methods differed across of recent quitting activity and the extent to which health countries. The sample sizes for the different surveys yield professionals are advising their clients/patients to quit 95% confidence intervals (CIs) of approximately 4% for smoking in 15 countries participating in the Interna- prevalence estimates approximately 20%, and 5% for tional Tobacco Control (ITC) policy evaluation surveys. prevalence estimates of approximately 50%. These data We also examined those who have made recent quit are not presented alongside the actual data, so that the attempts and report on levels of reported use of a variety focus remains on the overall range of estimates across of forms of help, both medication and non-medication. countries and not on detailed comparisons between We expected levels of quitting activity to be a function of countries. Methods were adopted to make the surveys as extent of public education and other tobacco control representative as possible for the populations sampled, efforts in the country, and use of support to be a function and we have used weighting by survey weights to both of these and of the availability and accessibility of increase further the representativeness of the results. support within a country. Face-to-face surveys used multi-level stratified sampling. The data are provided not to make fine-grained com- Telephone surveys usually used random digit dialling, parisons between countries, but to assess large-scale dif- and the internet sample came from a large, broadly rep- ferences and to analyse their implications. resentative, panel. Because recruitment into the ITC surveys is only of current smokers, we have restricted the analyses to those METHODS who were currently smoking at the time of the target The data came from 15 countries, ranging from high- to survey, for countries where the wave used was not the middle-income, that are surveying smokers as part of the first wave. This mode of sampling underestimates quit- ITC policy evaluation project. The ITC surveys are longi- ting activity by the proportion of quit attempts that Table 1 Characteristics of the samples of current smokers in the International Tobacco Control (ITC) Project countries. Survey Country Year of survey n Mode Sample wave High incomea New Zealand 2007 -2008 1376 Telephone National 1 Australia 2007–2008 1775 Telephone National 6 Canada 2007–2008 1697 Telephone National 6 United States 2007–2008 1723 Telephone National 6 United Kingdom 2007–2008 1657 Telephone National 6 Ireland 2006 582 Telephone National 3 Netherlands 2009 1637 Telephone and internet National 3 Germany 2009 912 Telephone National 2 France 2008 1540 Telephone National 2 South Korea 2008 1737 Telephone National 2 Middle income Uruguay 2006 885 Face-to-face Capital city 1 Mexico 2007 941 Face-to-face 4 cities 2 China 2007–2008 4623 Face-to-face 6 cities 2 Thailand 2006 1874 Face-to-face National 2 Malaysia 2006–2007 1564 Face-to-face and telephone National 2 More details on the individual surveys are available from the ITC website: http://www.itcproject.org. aIncome status of countries is based on the latest World Bank classification. See http://data.worldbank.org/about/country-classifications/country-and-lending-groups. © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
3.
Cessation assistance reported
by smokers in 15 countries 199 occurred in the period asked about, but were ongoing at specialists)’?. Where the questions refer to different time the time of the survey. One implication is that the quit intervals across countries, these are indicated clearly in attempts under discussion have been unsuccessful and the Results. somewhat shorter on average. Use of specific aids among those reporting making quit attempts Ethical clearance Interest in quitting is one major factor determining Ethical clearance for the various components of this demand for services and/or aids. To control in part for study were gained from the appropriate institutions in varying levels of interest in quitting across countries, we all participating countries. explore use of specific aids among those reporting having made a quit attempt in the relevant period. This excludes Measures a small proportion of those who reported using a quit aid Quit attempts in last year and ever but failed to report a quit attempt. At the initial survey, smokers were asked if they had ever tried to quit smoking and how recently their last attempt RESULTS ended. For subsequent waves smokers were asked: ‘Have Quitting activity you made any attempts to quit smoking since we last talked to you in (with date inserted)?’, and if so, when. Recent quitting activity varied considerably by country Only those reporting attempts in the last year were (Fig. 1). Reports of ever having tried to quit varied from included as having made recent attempts. approximately 60% in New Zealand, Mexico and China to more than 80% in most of the other countries. Fewer than 20% of smokers in China and Malaysia reported Visits to health professionals and advice about quitting recent attempts to quit compared with approximately Respondents were asked: ‘Have you visited a doctor 50% among smokers in Thailand. There was no clear or other health professional since last survey date?’ relationship between the two measures; for example, New (for recontacted smokers, or ‘in the last year’ for newly Zealand had low ever-quit rates but high recent quitting; recruited smokers). Those who had visited were further Germany had high ever-quit rates, but low levels of asked: ‘During any visit to the doctor or other health pro- recent activity. fessional, since last survey date (or in the last year), did you receive advice to quit smoking?’. Health professional advice To ascertain the potential for health-care consultations to Use of medications be an important locus for providing advice and motiva- tion to quit smoking, we asked about visits to doctors or Smokers were asked: ‘In the last year (since <insert last other health professionals for any reason. The level of survey date> have you used any stop-smoking medica- such visits varied enormously, from 50% to 70% in most tion?’; and if so, what, with nicotine replacement therapy of the developed countries to fewer than 20% in Malaysia (NRT) and prescription medications distinguished from (Fig. 2). The likelihood of reporting obtaining advice to other remedies. In countries where we had reason to quit when they visited also varied markedly (Fig. 2). In believe that knowledge of stop smoking medications some countries, including the United States, Thailand would be low the questioning was different. We first and Malaysia, more than two-thirds of those visiting a asked: ‘Have you heard about medications to help people health professional reported obtaining advice, while in stop smoking, including nicotine gum or patches, stop others, most notably the Netherlands, it was a clear smoking pills, such as bupropion or herbal medications?’. minority, approximately 20%. This translates into overall Only those who knew of such products were asked about advice to quit from health professionals ranging from less use; the remainder were assumed not to have used. than 10% in the Netherlands to more than 50% in the United States. Use of quitlines, internet and dedicated clinics Use of cessation supports Respondents were asked: ‘In the last year (last survey date, or 6 months in some cases), have you received Reported use of cessation support was restricted to those advice or information about quitting smoking from any of who reported making quit attempts, as this is the main the following? Telephone or quitline services; the inter- factor determining use. Figure 3 shows much higher use net; and ‘local stop smoking services (such as clinics and of quit smoking medications among those who made quit © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
4.
200
Ron Borland et al. 100% Evertried 90% Tried in last year 80% Percent making attempts 70% 60% 50% 40% 30% 20% 10% Figure 1 Reported history of quit attempts by country.The total height of the 0% bars refers to ever quit and the bottom part to those where there was an attempt SA Au NZ C lia a G nds Fr y ru e M y o Th na M and a a K he nd an a ad U nc ic si re U in the last year; 95% confidence intervals ra gu hi ex ay U N Irela Ko rla m a an l st C ai al er (of the total height) are presented at the et top of the bars 80% Visited, but no advice 70% Visited and advised Percent visited doctors & advised 60% 50% 40% 30% 20% 10% Figure 2 Reported visits to doctors or other healthcare professionals and of 0% advice to quit on any such visit by country. Interval is last year (or between waves), USA NZ Australia Canada Netherlands Germany France Uruguay Mexico China Thailand Malaysia Korea UK Ireland except where indicated with an asterisk *, where it is 6 months; 95% confidence inter- vals (of the total height) are presented at the top of the bars attempts in the previous year in western countries (more Use of advice-based behavioural supports was typi- than 40% in Australia, Canada, United Kingdom and cally considerably lower than use of medications. Use of United States) than in the low- and middle-income coun- the quitlines (Fig. 4) ranged from a high of 12% in New tries, with negligible levels of recent use reported from Zealand to very low levels in some countries where the Malaysia. Germany had notably low levels of use among question was asked, but where facilities are known to be the high-income countries. Korea had a moderate level of very limited. Surveys did not assess quitline use in coun- medication use, consistent with programmes supporting tries where no service was offered. cessation there and Korea’s relatively advanced economic Use of the internet for cessation support varied con- conditions. siderably (Fig. 5). Smokers in the Netherlands reported © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
5.
Cessation assistance reported
by smokers in 15 countries 201 60% Percent using medications 50% 40% 30% Figure 3 Reported use of quit smoking 20% medications in the last year, or between survey waves. Reported only among those 10% reporting making quit attempts in the pre- vious year. France did not ask for recent 0% N/A use; 95% confidence intervals are pre- SA Au NZ C lia a G nds Fr y U ce M y o Th n a M nd a a K he d an a ad ic si re U sented at the top of the bars. #The bar et an ra an gu hi la ex ay U Ko rla m an st C ai N Irel ru al er indicated is based on very small numbers of ‘yes’ answers (<5 cases) 16% 14% Percent using quitlines Figure 4 Reported use of quitlines (or 12% related services) for assistance in smoking 10% cessation (in the last year (previous survey), 8% except where indicated by an asterisk, where it was for the last 6 months) by 6% country, among those reporting making 4% quit attempts in the previous year. Ques- tion not asked in Uruguay or Mexico 2% because quitline did not exist at survey 0% N/A N/A administration; 95% confidence intervals SA Au NZ C lia a G nds Fr y U ce M y o Th na M nd a a K he d an a ad ic si re U et an are presented at the top of the bars. #The ra an gu hi la ex ay U Ko rla m an st C ai N Irel ru al er bar indicated is based on very small numbers of ‘yes’ answers (<5 cases) 25% Percent using internet 20% 15% Figure 5 Reported use of the internet as a source of smoking cessation advice (in the previous year except where indicated 10% by an asterisk, where it is 6 months) by country among those reporting making 5% quit attempts in the previous year. Coun- tries not listed here were not asked; 95% 0% confidence intervals are presented at the SA Z lia a K s y ce ay o a he d nd an ad ic re N U n top of the bars. #The bars indicated are ra an gu ex U la Ko rla m an st Ire Fr ru M er Au C based on very small numbers of ‘yes’ U G et N answers the highest use of the internet for quitting (nearly 20% of Similarly, the use of dedicated smoking cessation those making attempts), followed by the United States clinics was low (Fig. 6), with use of such services highest (approximately 13%), with lower levels in other countries in the United Kingdom, which has a dedicated network of where we asked. The high level of use in the Netherlands clinics. From several countries we have no comparable is likely to be due partly to most of that sample being data, but in some of these at least we can be fairly sure surveyed on the internet, although the rate for this sub- that use of such services is minimal, as few if any are sample was non-significantly higher in internet use than known to exist, and those that do are small and very that for the telephone-surveyed subsample. localized. © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
6.
202
Ron Borland et al. Percent using specialist services 25% 20% 15% Figure 6 Reported use of specialist ces- 10% sation services (e.g. clinics) in the past year (or where *, 6 months) among those 5% reporting quit attempts in the previous year. This question was not asked in the 0% other countries or a non-comparable ques- SA tion was used; 95% confidence intervals are Z ia a K s y ce a d nd an ad re N U l an ra an presented at the top of the bars. #The bar U Ko rla m an st l Ire Fr er Au he C indicated is based on very small numbers G et N of ‘yes’ answers DISCUSSION than those reported here, while the reverse was the case in Thailand, where the data reported here followed its first There are considerable differences between countries in large-scale mass media campaign. Published evidence the level of quitting activity and the level and type of also shows that other population-level activities such as support used. This variation reflects some combination of the introduction of stronger health warnings on cigarette differences in the history of tobacco control efforts, the packages [10] and increases in the price of tobacco pro- capacity of the country or its smokers to afford different ducts can increase quitting activity in a population quit methods and the priority given to specific tobacco [11,12]. control policies (e.g. the relative emphasis given to public One of the most striking findings is the diversity across education, regulatory measures and provision of cessa- countries in the use of health professionals and in the tion assistance); and doubtlessly, more general cultural encouragement they provide for quitting. Overall, the factors. lower-income countries reported fewer visits to health Generally speaking, less wealthy countries have fewer professionals; for example, Mexico and Malaysia were resources available to invest in smoking cessation rela- particularly low. However, on a note of caution, the low tive to higher-income countries, both from governments level of reporting visits in Malaysia, coupled with the and individuals. Our data showed that compared to high level of reporting obtaining advice, raises the possi- smokers in those high-income countries, smokers in bility that some smokers, at least in Malaysia, answered middle-income countries generally reported lower-level about visiting health professionals in relation to their use of quitting smoking medications and health profes- smoking, not visits in general. The Malay translation of sional services, but not always less interest in quitting. this question makes it less clear than elsewhere that any Thailand, for example, reported the highest level of visit is meant. That said, there is little doubt that some of recent quit attempts, due probably to this survey follow- the differences we report are real. We suspect that in ing its first major mass media campaign, backed by many, if not most, of the world’s poorer countries, levels several years of legislative reforms and a revered king of visiting health professionals will be even lower than who speaks strongly against tobacco use. Having a those reported here for the middle-income countries. population educated about the harms of smoking and The potential role of health professionals in encourag- where smoking is institutionally discouraged may be a ing cessation is likely to be more limited in countries necessary condition for high levels of smoking cessation where smokers consult them less frequently. Further, activity, but other factors are also clearly important when visits are more rare, the presenting problems may in determining the extent to which this translates be more serious, and time constraints may be more likely into use of help and or provision of advice by health to squeeze out mention of smoking cessation, especially professionals. where it is not relevant to the reason for the consultation. Published evidence shows that mass media cam- The highest levels of advice to quit were found in the paigns to encourage quitting make a large difference to United States, where there has been a great deal of effort quitting activity [9], and we see this in our as-yet unpub- to encourage doctors to apply evidence-based guidelines, lished data. For example, earlier waves of the ITC surveys including those for smoking cessation [13] based on in Korea and Malaysia, taken just after or during large evidence that such advice can motivate quitting [4]. campaigns, found rates of recent quitting much higher However, our data suggest that in some countries doctors © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
7.
Cessation assistance reported
by smokers in 15 countries 203 are not providing advice as often as they might. For believe that this is something that they need help to do, example, we found low rates of providing advice in the and then they need to believe that some form of available Netherlands. We understand that many Dutch physi- help is likely to assist them. They also need to have the cians are reluctant to intervene with what many consider idea of using aids at the top of their minds, and as there the right of patients to ‘choose’ the life-style they want. may be less promotion of aids when they are subsidized, As a result, most restrict their advice on this matter this might act to counter the use promoting function of to patients with smoking-related complaints. However, reduced price. To the extent that the low use in some reporting that doctors do not seem to take smoking ces- places reflects low demand, then it will be important to sation seriously [14] is a commonly voiced rationalization create more interest in quitting smoking and a greater for continuing to smoke, at least in those western coun- realization of the benefits of assistance before rates of use tries where it has been studied. Tobacco control advocates are likely to approach those achieved in countries where should try to convince doctors who are reluctant reported use levels are nearing half of those making quit to provide advice that free choice necessarily involves attempts. having adequate knowledge relevant to that choice, and Use of other forms of assistance was generally lower thus they, as health experts, have a responsibility for than use of cessation medications. The forms of support, ensuring that their patients have a realistic understand- as well as the overall amount, vary by country. For ing of how continuing to smoke risks compromising their example, New Zealand and Australia provide most assis- long-term health. Doctors should raise the issue, encour- tance through quitlines, while the United Kingdom age cessation to reduce risks, discuss options and offer focuses on face-to-face services, and the internet is the whatever help they can (e.g. referring or otherwise point- preferred delivery mode in the Netherlands. The relatively ing their patients/clients in the direction of evidence- high quitline use in New Zealand probably reflects its pro- based forms of assistance where they are available). vision of heavily subsidized NRT [16], and in both Aus- Even in the country where smokers are most likely to tralia and New Zealand heavy promotion of the services, receive quit advice from health professionals (the United including having the telephone number on cigarette States), our data suggest that only half of all smokers packs as part of the health warning material, clearly con- receive any such advice each year. This highlights the tributes to the higher levels of use [17]. In the Nether- importance of reaching many smokers through interven- lands, high level of internet use is related to very high tions outside the formal health system, such as mass high-speed internet access (>90% of the population) media campaigns or pictorial pack warnings that and the wide promotion of internet-based cessation promote quitting. Population-level interventions are a support by STIVORO, including tailored advice on a self- critically important part of encouraging smokers to use help smoking cessation website, all integrated with the whatever help is available if they feel unable to quit national telephone quitline [18]. All mass media cessa- without assistance. Further, promoting services to assist tion campaigns refer to the website and not the quitline cessation may help to make public information cam- number, so the website is seen as the first place to go. paigns more effective because they signal the importance The generally low level of use of help, even in coun- of taking action. tries where smoking prevalence has reduced markedly As would be expected, use of smoking cessation medi- and such help is widely available, shows that availability cations also varied greatly by country, undoubtedly due of help is not sought by many, and is not necessary to greatly to limits on affordability and availability in some make progress in reducing prevalence. However, help can countries. In some countries, typically richer ones, cessa- play an important role because smokers can increase tion medications are paid for or subsidized by the govern- their chances of quitting by using it, and there is some ment (e.g. United Kingdom, New Zealand) or health evidence that the provision of services can also encour- insurance schemes (for many in the United States), and age self-quitting [19]. this is likely to increase use. Germany, which is rich and It is important to be clear about the limitations of where medications are widely available and promoted, these multi-country comparisons and how they limit the but which has no subsidies, had low levels of use of medi- conclusions that can sensibly be drawn. This paper is cation. However, the role of subsidies is not always a designed to provide an overview of some large-scale major factor. For example, Australia had much high differences between countries to stimulate thinking as to levels of medication use, most being NRT, which is not why and what the implications of these large differences subsidized [15]; and New Zealand, with a sophisticated might be for policies that relate to the provision of and widely available subsidy scheme, has relatively low supports for smoking cessation. Small differences (for levels of medication use. example, fewer than 5%) should be interpreted with Before smokers will begin to use aids, they must want extreme caution, and then only as a suggestion of the to or at least be convinced of the need to quit smoking, need to seek corroborating data from other sources to © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
8.
204
Ron Borland et al. determine if they do reflect an underlying reality. The ITC low- and middle-income countries because contacts with Project interviews were completed in several languages, such services are less common. Population-based strate- and although we took care with translations to equate gies will be even more important in these countries to concepts, inevitably the nuances of words differ and these encourage smokers to consider quitting and, where nec- differences may have had some effect on the results. We essary, to seek out help. These strategies include mass only surveyed smokers, so we miss quitting activity from media campaigns, pictorial health warnings on tobacco recent quitters, thus underestimating quitting activity packaging and higher taxes on tobacco products [1], and marginally, but this is common for all countries. Similarly, can produce rapid variations in interest in quitting different data collection modes (e.g. face-to-face inter- and quit-related activity. Cessation services can and do views versus telephone interviews) might have had some provide useful functions. Countries need to consider how effect, as might differences in response rates. In analyses to provide such services (including both pharmaceuticals not reported here we have looked at both kinds of differ- and advice-based help) in ways that best fit into their ences. In countries where we used mixed modes of existing health-care system, and to ensure that they are responding, we do not find large survey mode differences. accessible, affordable and widely promoted. Even where We have also looked for differences in responding between an extensive range of services and aids are available and new recruits into our survey and those retained from pre- promoted many smokers do not use them, suggesting vious waves (an increasingly less representative group), that demand for such services is something that only and have found only no or small effects (in the order of grows gradually with prolonged public education and 2–3% differences in estimates), so sampling effects prob- denormalization of smoking. Allowing services to grow ably contribute only a small amount to the variance. organically with demand is one way to maximize benefits Further interwave intervals varied and even where we and to minimize initial costs. asked about a set period, having a reference of a previous survey close to the reference time might have affected Declarations of interest responding. We do not know the size of such effects but believe they are typically small, are most likely to affect No author has any conflict of interest, although some reports of events occurring (e.g. of quit attempts and the have associations with organizations that deliver use of health professionals) rather than what was con- smoking cessation services. ducted on such occasions (use of aids). Further, any biases due to different levels of familiarity with the form of Acknowledgements assistance would most probably have acted to reduce the observed differences: over-reporting the rare and under- The major funders of multiple surveys were: National reporting the more commonplace (e.g. any use of medi- Cancer Institute, US (P50 CA111326): (RO1 CA cation, even trying, might be reported where use of 100362) (R01 CA125116); Canadian Institutes for medication is rare, but in a context of widespread use Health Research (79551); and Ontario Institute for more extensive use might be expected before the person Cancer Research (Senior Investigator Award). In addi- would report ‘really’ using it on a quit attempt). Finally, in tion, major support for individual countries came from: some countries (China, Mexico, Uruguay) we only sur- National Health and Medical Research Council of Aus- veyed in some cities, so these results should not be gener- tralia (450110); Cancer Research UK (C312/A3726), alized to the entire countries, particularly not to rural Chinese Center for Disease Control and Prevention; areas where conditions are much different. We believe Bloomberg Global Initiative—Union Against Tuberculo- that the differences we highlighted are likely to be real sis and Lung Disease (Mexico 1-06) and the Mexican between-country differences, but reiterate that readers National Council on Science and Technology (CONACyT should not interpret differences between countries of less Salud-2007-C01-70032); French Institute for Health than approximately 5% without corroborating evidence. Promotion and Health Education (INPES), French This study included 10 high-income and five middle- National Cancer Institute (INCa); German Cancer income countries, but no data were available from the Research Center, German Ministry of Health; Dieter low-income countries included more recently in the ITC Mennekes-Umweltstiftung; the Netherlands Organiza- study (e.g. Bangladesh). Future studies of this kind will tion for Health Research and Development (ZonMw); be able to include such countries, using both ITC data New Zealand Health Research Council; The National and data from other sources, such as the Global Adult Cancer Center of Korea (from Ministry of Health and Tobacco Survey (GATS). Welfare). The funding sources had no role in the study This study shows that tobacco control strategies that design, in collection, analysis and interpretation of data, focus on service delivery, or advice-giving, within the in the writing of the report or in the decision to submit health-care system are likely to have limited impact in the paper for publication. © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
9.
Cessation assistance reported
by smokers in 15 countries 205 References health warnings influence quitting: findings from the ITC Four Country survey. Addiction 2009; 104: 669–75. 1. World Health Organization. WHO Report on the Global 11. Jha P., Chaloupka F. J. Curbing the Epidemic: Governments and Tobacco Epidemic, 2008. The MPOWER Package. Geneva: the Economics of Tobacco Control. Washington, DC: The World Health Organization; 2008, p. 36–8. World Bank; 1999. 2. Raw M., Regan S., Rigotti N., McNeill A. A survey of tobacco 12. Reed M., Anderson C. M., Vaughn J. W., Burns D. M. The dependence treatment services in 36 countries. Addiction effect of cigarette price increases on smoking cessation in 2009; 104: 279–87. California. Prev Sci 2008; 9: 47–54. 3. Raw M., McNeill A., Murray R. Case studies of tobacco 13. Fiore M. C., Bailey M. D., Cohen D. J., Dorfman S. F., dependence treatment in Brazil, England, India, South Goldstein M. G., Gritz E. R. Treating tobacco use and depen- Africa and Uruguay. Addiction 2010; 105: 1721–8. dence. Clinical Practice Guideline. Rockville, MD: US 4. Stead L., Bergson G., Lancaster T. Physician advice for Department of Health and Human Services, Public Health smoking cessation. Cochrane Database Syst Rev 2008; 2: Service 2000. CD000165. DOI: 10.1002/14651858.CD000165.pub3. 14. Mullins R., Borland R. Doctors’ advice to their patients 5. Cahill K., Stead L. F., Lancaster T. Nicotine receptor partial about smoking. Aust Fam Physician 1993; 22: 1146–55. agonists for smoking cessation. Cochrane Database Syst Rev 15. Cooper J., Borland R., Yong H. Australian smokers increas- 2008; 3: Art. No.: CD006103. doi:10.1002/14651858. ingly use help to quit, but number of attempts remain CD006103.pub3. stable: findings from the International Tobacco Control 6. Stead L. F., Perera R., Bullen C., Mant D., Lancaster T. Nico- Study 2002–09. Aust NZ J Public Health 2011; 35: 368– tine replacement therapy for smoking cessation. Cochrane 76. Database Syst Rev 2008; 1: Art. No.: CD000146. doi:10. 16. Wilson N., Weerasekera D., Borland R., Edwards R., Bullen 1002/14651858.CD000146.pub3. C., Li J. Use of a national quitline and variation in use by 7. Lancaster T., Stead L. F. Self-help interventions for smok- smoker characteristics: ITC Project New Zealand. Nicotine ing cessation. Cochrane Database Syst Rev 2005; 3: Art. No.: Tob Res 2010; 12: S78–84. CD001118. doi:10.1002/14651858.CD001118.pub2. 17. Wilson N., Weerasekera D., Hoek J., Li J., Edwards R. 8. Stead L. F., Perera R., Lancaster T. Telephone counselling Increased smoker recognition of a national quitline number for smoking cessation. Cochrane Database Syst Rev 2006; 3: following introduction of improved pack warnings: ITC Art. No.: CD002850. doi:10.1002/14651858.CD002850. Project New Zealand. Nicotine Tob Res 2010; 12: S72–7. pub2. 18. TNS Opinion & Social. Special Eurobarometer 335: 9. Wakefield M., Durkin S., Spittal M. Impact of tobacco e-communications household survey. Survey requested by control policies and mass media campaigns on monthly the European Commission (EC), Brussels. 2010. adult smoking prevalence. Am J Public Health 2008; 98: 19. Ossip-Klein D. J., Giovino G. A., Megahed N., Black P. M., 1–8. Emont S. L., Stiggins J. et al. Effects of a smoker’s hotline: 10. Borland R., Yong H. H., Wilson N., Fong G. T., Hammond D., results of a 10-country self-help trial. J Consult Clin Psychol Cummings K. M. et al. How reactions to cigarette pack 1991; 59: 325–32. © 2011 The Authors, Addiction © 2011 Society for the Study of Addiction Addiction, 107, 197–205
Baixar agora